- BioSig Technologies (BSGM, Financial) has signed an LOI to merge with Streamex Exchange Corp in an all-stock transaction.
- This merger aims to create a publicly listed real-world asset tokenization company on Nasdaq.
- Former Streamex stockholders will own approximately 75% of the merged company's common stock after the transaction.
BioSig Technologies Inc. (BSGM), a medical technology company, announced its entry into a Letter of Intent (LOI) to merge with Streamex Exchange Corporation. The proposed all-stock transaction is designed to create a publicly listed company specialized in real-world asset tokenization, leveraging Streamex's fully developed primary issuance and decentralized exchange infrastructure tailored for on-chain commodity markets.
The merger signifies a strategic pivot for BioSig from its current medical technology business model to a focus on blockchain technology and digital asset tokenization. Streamex provides a robust technology stack that facilitates the tokenization of real-world assets, offering a financing platform that streamlines investment processes, enhances capital availability, and expands investor opportunities.
Upon completion of the merger, Streamex's stockholders will hold approximately 75% of the outstanding common stock of the newly formed entity, while BioSig's current stakeholders will own the remaining equity. This transaction marks a significant transformation and growth potential for BioSig's business and its shareholders, as articulated by BioSig's CEO, Anthony Amato.
Streamex's platform is dedicated to bridging the gap between traditional finance and the digital economy by bringing commodity markets on chain. This evolution aims to unlock new opportunities for investors and institutions globally, supported by seasoned executives from the financial, commodities, and blockchain sectors.
As part of the merger agreement, Mr. Henry McPhie, Co-Founder and CEO of Streamex, will assume the role of Chief Executive Officer and board member of the merged entity. Mr. Morgan Lekstrom, Co-Founder and Chairman of Streamex, will join as Chairman of the Board. The transaction also includes the addition of strategic advisors such as Mr. Frank Giustra and Mr. Mathew August, bringing their extensive experience in commodities and US capital markets, respectively.
